REDWOOD CITY, CA--(Marketwire - July 28, 2009) - Facet Biotech Corporation (NASDAQ: FACT) today announced that it will release its financial results for the second quarter 2009 following the close of the U.S. financial markets on Tuesday, August 4, 2009. Following the release, Facet will hold a conference call at 4:30 p.m. Eastern Time to discuss these financial results and provide an update on company activities.
A live webcast of the conference call will be available through the Facet website: www.facetbiotech.com. Please connect to this website at least 15 minutes prior to the live webcast to allow time for any software download that may be needed to hear the webcast. Financial and statistical information to be discussed in the call will be available on the Facet website immediately prior to the commencement of the call. A replay will be available at www.facetbiotech.com starting approximately two hours after completion of the webcast.
An audio replay will also be available by telephone from approximately 6:30 p.m. Eastern Time on August 4, 2009 through 6:30 p.m. Eastern Time on September 4, 2009. To access the replay, dial 800-642-1687 from inside the U.S. and 706-645-9291 from outside the U.S.; enter conference ID number 22473699.
About Facet Biotech
Facet Biotech is a biotechnology company dedicated to advancing its pipeline of four clinical-stage products, leveraging its research and development capabilities to identify and develop new oncology drugs and applying its proprietary next-generation protein engineering technologies to potentially improve the clinical performance of protein therapeutics. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.
NOTE: Facet Biotech and the Facet Biotech logo are considered trademarks of Facet Biotech Corporation.
Contact:
Jean Suzuki
Investor Relations
(650) 454-2648
jean.suzuki@facetbiotech.com
